Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Valeant Pharmaceuticals: Revisiting My $57 Price Target [Seeking Alpha]

VALEANT PHARMACEUTICALS (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com
Company Research Source: Seeking Alpha
Valeant Pharmaceuticals: Revisiting My $57 Price TargetSummaryI continue to believe assets sales are the key for Valeant shares to see higher levels.Based on my latest figures, shares could reach as high as $54 a share, if enough assets are sold.I continue to think VRX is a buy, but there will be wild swings in the interim. Show less Read more
Impact Snapshot
Event Time:
VRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VRX alerts
Opt-in for
VRX alerts

from News Quantified
Opt-in for
VRX alerts

from News Quantified